Arvinas Company
PROTAC® (PROteolysis TArgeting Chimera) Discovery Engine to design and build a new class of oral protein-degrading medicines.
Headquarters:
USA
Investor Type:
Venture Capital Funds
Founded Date:
2013
Industry:
FemTech
Total Funding:
> $1.5 B